Bu Yaolian was a man nearing fifty, the head of the testing department at China's drug administration. All new drug approvals for domestic pharmaceutical companies had to pass his scrutiny and signature.
Lately, Bing Tian Pharmaceutical had been frequently targeted, their new drug launches repeatedly stalled, all orchestrated by Bu Yaolian.
While his position wasn't that of a high-ranking official, his authority was considerable. He could, with a single word, determine the fate of pharmaceutical enterprises.
Consider this: the marketability of new drugs, on which these companies spent billions, depended entirely on when he chose to sign and seal the approval.
If he decided to cause trouble and obstruct the approval process, most pharmaceutical companies simply couldn't withstand it.
Originally, the anti-cancer drug, Bing Tian Zheng Qi Tang, submitted by Bing Tian Pharmaceutical for testing and approval, had garnered significant attention from numerous medical institutions and research institutes.
This was because Bing Tian Pharmaceutical's previous products, whether cosmetics or the diabetes-treating Bing Tian Xiao Ke Wan, had been bestsellers. Their latest product naturally attracted even more attention.
Especially for anti-cancer drugs, despite pharmaceutical companies worldwide investing vast sums annually, most of these medications had proven to be scams, with invested funds going down the drain.
The product submitted by Bing Tian Pharmaceutical for review was indeed extraordinary. Its efficacy for cancer patients reached over ninety-five percent. Most patients who showed no significant improvement were those with severely weakened bodies, on their last legs, and with completely collapsed immune systems; even for them, there was little that could be done.
Medical institutions cooperating with the clinical trials were particularly eager to introduce this drug. After all, cancer progresses rapidly, and many cancer drugs even develop resistance with prolonged use.
Moreover, such an effective anti-cancer drug was reasonably priced. These medical institutions did not want to miss this opportunity to gain fame and profit!
Bing Tian Zheng Qi Tang truly lived up to expectations, with its clinical trial data being exceptionally impressive. However, just as Section Chief Bu Yaolian was preparing to sign and seal the approval, someone contacted him, instructing him to halt the process.
Having reached his position, Bu Yaolian was undoubtedly a shrewd operator and dared not refuse. Thus, the approval was suspended. To provide an explanation to Bing Tian Pharmaceutical, he asked them to return and prepare the materials.
A few days later, he received news that the product could be launched.
Bu Yaolian then instructed his subordinates to continue the approval procedures. However, before the process was even completed, another directive came from above, ordering him to terminate the approval process.
This time, the person issuing the directive seemed to have even greater influence. Bu Yaolian had no choice but to comply. Over a month later, another message arrived stating that the drug could be released.
Bu Yaolian was becoming depressed by the constant back and forth. This time, he didn't rush to agree, as each approval involved too many procedures and processes. As expected, another message arrived, instructing them to continue blocking Bing Tian Pharmaceutical's new drug approval.
It wasn't until a few days prior that Bu Yaolian's direct superior personally approached him, instructing him not to continue obstructing Bing Tian Pharmaceutical and to expedite the approval process as long as the product was compliant, treating it as a special case.
Fearing further reversals, Bu Yaolian informed his superior about these events. His superior told him that the individuals who had intervened this time had unprecedented influence.
The Xuanyuan family had personally intervened, backed by the Righteous Path Alliance. Consequently, Bing Tian Pharmaceutical's new drug, Bing Tian Zheng Qi Tang, finally received market approval!
The drug's price was very affordable, with the final retail price not exceeding 200 yuan, making it accessible to the vast majority of patients.
Furthermore, after a period of medication to completely clear cancer cells from the body, taking it once a week thereafter could effectively prevent recurrence.
This was incredibly cheap compared to expensive imported anti-cancer drugs that cost thousands of yuan per day for treatment.
As soon as it received approval, Bing Tian Pharmaceutical's accumulated production from several months was snapped up. Numerous medical institutions directly offered cash for advance payments, with orders already booked for two years later!
This immediately caused domestic and international pharmaceutical manufacturers, especially those producing anti-cancer drugs, to become restless.
In comparison to Bing Tian Pharmaceutical's product, the offerings from domestic pharmaceutical manufacturers seemed like a rip-off, while the efficacy of those high-priced imported anti-cancer drugs appeared rather meager when compared to Bing Tian Zheng Qi Tang.
With an affordable and effective drug available, who would buy expensive products with compromised efficacy! Even the government was promoting Bing Tian Zheng Qi Tang as a replacement for costly imported medications.
Consequently, in recent times, Bing Tian Pharmaceutical had become the darling of both medical and financial media.
According to projections from relevant commercial institutions, this single product from Bing Tian Pharmaceutical was expected to generate over 50 billion yuan in annual sales. If their expansion and production capacity could keep pace in the future, achieving annual sales exceeding 100 billion yuan would not be difficult.
Currently, Bing Tian Pharmaceutical's market valuation had surpassed 200 billion yuan, making it an undisputed leading pharmaceutical company in China. Only those pharmaceutical manufacturers with a monopoly in certain fields or drug categories commanded such valuations!
As a result, various investment institutions and pharmaceutical companies flocked to Bing Tian Pharmaceutical, seeking joint ventures or equity stakes.
However, this time, they were met with rejection. Bing Tian Pharmaceutical directly told them no!
Besides having the colossal Tian Xi Group as their shield, the Situ family also issued a warning: anyone who dared to lay a hand on Bing Tian Pharmaceutical would face the wrath of the Situ family!
In addition to having protection, Bing Tian Pharmaceutical's president, Wang Qing Tian, was also much more at ease. Ling Tian, disguised as Zhang Er Xi, acted as his executive assistant and participated in several negotiations.
With Ling Tian on the job, he was worth ten men. He utilized what he had learned from his fifth master, Gu Tian Xi, to completely overwhelm those who sought to encroach upon Bing Tian Pharmaceutical.
Even when these parties adopted aggressive tactics and attempted to exert pressure on Bing Tian Pharmaceutical through various underhanded means, Ling Tian quietly neutralized them all.
Ling Tian thoroughly enjoyed this life. After all, the martial arts world of China was in disarray, and the Situ family was entangled in a conflict with the Tianshan Sword Sect. Both sides were now locked in a brutal battle.
Ling Tian, the instigator of all this, remained on the sidelines, observing coldly. This allowed him to avoid being affected by the various factions who had lost their minds in their pursuit of vengeance.